Some diseases are more likely to enter public conversation than others. Covid-19 has dominated the public discourse in 2020...
Michael Head 22 Apr 2021
As a young medical doctor over 30 years ago, I had an experience no doctor wants to have. One of my patients, a young boy, died in my arms as we rushed him to the referral hospital in Nairobi, Kenya, to receive treatment...
Monique Wasunna 29 Jan 2021
African countries are still reeling from the effect of measures, such as lockdowns, taken to contain the spread of Covid-19...
Monique Wasunna 12 Nov 2020
Recently published estimates put the burden of disease due to fungal infection in South Africa at more than 3 million cases per year. These figures are especially shocking given that prior to 1980, fungal infections were not a major health problem...
Strides in medicine have contributed to a dramatic increase in life expectancy over the last century. Diseases like HIV and cervical cancer that were essentially death sentences as recently as 30 years ago can now be managed...
James Leahy 28 Oct 2019
Leishmaniasis ranks on the World Health Organisation's list of neglected tropical diseases, along with the usual suspects such as dengue, chikungunya and rabies...
Ramona Hurdayal & Raphael Taiwo Aruleba 15 Jul 2019
Half a century ago concerns about climate change, environment vulnerability, population density and the sustainability of earth systems reached a broad audience.
Lenore Manderson 17 Sep 2018
We say goodbye to 2016 by looking back at the healthcare stories that made headlines...
LAURA LOPEZ GONZALEZ 30 Dec 2016
Rheumatic heart disease (RHD) is the most commonly acquired heart disease in children around the world.
Research from Frost & Sullivan indicates that breakthrough therapies for rare diseases command premium pricing, particularly if no alternatives exist.
Yesterday at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, the Drugs for Neglected Diseases initiative (DNDi) announced the launch of a new drug development programme to address critical unmet treatment needs of children with HIV and AIDS.
Two South Africans are among 10 recipients of the 14th annual Rosalynn Carter Fellowships for Mental Health Journalism, named last week by the Mental Health Programme of The Carter Centre in Atlanta, Georgia.
In what is claimed to be a unique collaboration, TB Alliance and the Drugs for Neglected Diseases initiative (DNDi) have entered into a cross-disease license agreement to speed development of novel therapies for a range of diseases including TB.
Massachusetts Institute of Technology (MIT) and South Africa's Technology Innovation Agency (TIA) will join the Pool for Open Innovation against Neglected Tropical Diseases, Science|Business reports. According to Science|Business, "MIT is the first university to contribute intellectual property to the pool," while South Africa's TIA is the first government agency to join (5/6).
New approach to protein misfolding may lead to novel therapies for a number of diseases.
Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases. The findings are available online today in PLoS Neglected Tropical Diseases.
Two South Africans, Glynis Horning and Metzi van der Merwe, are among 10 recipients of the twelfth annual Rosalynn Carter Fellowships for Mental Health Journalism, named last week by the Mental Health Programme of The Carter Centre in Atlanta, Georgia.
The World Health Organization released staggering new data about the threat of tuberculosis and the toll it takes on people with HIV/AIDS today, in recognition of World TB Day.
People around the world are getting laid off, stock markets are hurting, and banks are going belly up. In an economic environment gone haywire, philanthropy often seems to be the last thing on peoples' minds. But like many other sectors, it is undergoing major changes.
Lucy-Claire Saunders 2 Mar 2009
Sudan is finding that it is unable to rebuild its health services because it lacks healthcare workers.
Bill Gates announced on Thursday that the Bill & Melinda Gates Foundation will provide US$168.7 million to PATH for its Malaria Vaccine Initiative to develop vaccines for malaria -- a disease that kills thousands of African children every day.
A tropical flesh-eating disease, Buruli ulcer, is spreading across West Africa and has infected at least 40,000 people leaving them with bloody infected wounds and swollen skin ulcers, which at their worst, require surgery or amputation, according to the World Health Organization (WHO).
A controversial new public health funding mechanism, intended to stimulate pharmaceutical companies to create vaccines for diseases that affect patients in developing countries, is close to being finalised.
Tatum Anderson 8 Jul 2008
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment research and development.
Two research organisations based in Paris, the Institut de Recherche pour le Développement (Institute of Research for Development) and the Drugs for Neglected Diseases Initiative, have announced that they will work together to develop new candidate drugs to treat visceral leishmaniasis, Chagas's disease, and sleeping sickness.
New Brazilian medicines emerge for local health problems. The same trend is seen in India and China.
While the WHO Intergovernmental Working Group (IGWG) met in Geneva in November to finalise their global strategy regarding access to new drug therapies, the International Alliance of Patients' Organizations (IAPO) concluded, in a separate meeting, that the top global priority is currently access to healthcare.
When people think of ill health in Africa, their minds immediately turn to AIDS, Malaria, Tuberculosis, Diarrhoea and Maternal Mortality among others.
NAIROBI – To help address critical gaps in malaria treatment and education, Pfizer today announced the launch of Mobilize Against Malaria. This three-country initiative comprising Kenya, Ghana and Senegal will be implemented over the course of five years (2007-2011).